The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Development and evaluation of AS03, an Adjuvant System containing α-tocopherol and squalene in an oil-in-water emulsion
Abstract
AS03 is an Adjuvant System composed of α-tocopherol, squalene and polysorbate 80 in an oil-in-water emulsion. In various nonclinical and clinical studies, high levels of antigen-specific antibodies were obtained after administration of an AS03-adjuvanted vaccine, permitting antigen-sparing strategies. AS03 has been shown to enhance the vaccine antigen-specific adaptive response by activating the innate immune system locally and by increasing antigen uptake and presentation in draining lymph nodes, a process that is modulated by the presence of α-tocopherol in AS03. In nonclinical models of the AS03-adjuvanted prepandemic H5N1 influenza vaccine, increased levels of anti-influenza antibody afforded protection against disease and against virus replication of influenza strains homologous and heterologous to the vaccine strain. By incorporating AS03 in the pandemic H1N1/2009 vaccine, vaccine immunogenicity was increased compared with nonadjuvanted H1N1 vaccines. High H1N1/2009/AS03 vaccine effectiveness was demonstrated in several assessments in multiple populations. Altogether, the nonclinical and clinical data illustrate the ability of AS03 to induce superior adaptive responses against the vaccine antigen, principally in terms of antibody levels and immune memory. In general, these results support the concept of Adjuvant Systems as a plausible approach to develop new effective vaccines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Updating the accounts: global mortality of the 1918–1920 "Spanish" influenza pandemic.
Johnson, N. P. A. S., & Mueller, J. (2002) · Bulletin of the History of Medicine · doi:10.1353/bhm.2002.0022 · Cited by 1,980
Vitamin E: function and metabolism
Brigelius‐Flohé, R., & Traber, M. G. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.10.1145 · Cited by 1,591
Vitamin E, antioxidant and nothing more
Traber, M. G., & Atkinson, J. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.03.024 · Cited by 1,478
Hayden, M. S., West, A. P., & Ghosh, S. (2006) · Oncogene · doi:10.1038/sj.onc.1209943 · Cited by 1,178
The rgp120 HIV Vaccine Study Group (2005) · The Journal of Infectious Diseases · doi:10.1086/428404 · Cited by 952
Stoute, J. A., Slaoui, M., Heppner, D. G., Momin, P., Kester, K. E., Desmons, P., Wellde, B. T., Garçon, N., Krzych, U., Marchand, M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701093360202 · Cited by 870
Self-citationMiller, E., Hoschler, K., Hardelid, P., Stanford, E., Andrews, N., & Zambon, M. (2010) · The Lancet · doi:10.1016/s0140-6736(09)62126-7 · Cited by 708
Safety and Immunogenicity of an Inactivated Subvirion Influenza A (H5N1) Vaccine
Treanor, J. J., Campbell, J. D., Zangwill, K. M., Rowe, T., & Wolff, M. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055778 · Cited by 698
Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in china
Han, F., Lin, L., Warby, S. C., Faraco, J., Li, J., Dong, S. X., An, P., Zhao, L., Wang, L. H., Li, Q. Y., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22587 · Cited by 512
Leroux-Roels, I., Borkowski, A., Vanwolleghem, T., Dramé, M., Clement, F., Hons, E., Devaster, J.-M., & Leroux-Roels, G. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61297-5 · Cited by 498
Response to a Monovalent 2009 Influenza A (H1N1) Vaccine
Greenberg, M. E., Lai, M. H., Hartel, G. F., Wichems, C. H., Gittleson, C., Bennet, J., Dawson, G., Hu, W., Leggio, C., Washington, D., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0907413 · Cited by 492
Huang, Z.-R., Lin, Y.-K., & Fang, J.-Y. (2009) · Molecules · doi:10.3390/molecules14010540 · Cited by 490
Morel, S., Didierlaurent, A., Bourguignon, P., Delhaye, S., Baras, B., Jacob, V., Planty, C., Elouahabi, A., Harvengt, P., & Carlsen, H. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.01.011 · Cited by 476
Self-citationBresson, J.-L., Perronne, C., Launay, O., Gerdil, C., Saville, M., Wood, J., Höschler, K., & Zambon, M. C. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68656-x · Cited by 411
H5N1 Influenza — Continuing Evolution and Spread
Webster, R. G., & Govorkova, E. A. (2006) · New England Journal of Medicine · doi:10.1056/nejmp068205 · Cited by 398
Jegerlehner, A., Schmitz, N., Storni, T., & Bachmann, M. F. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.9.5598 · Cited by 397
Squalene: A natural triterpene for use in disease management and therapy
Reddy, L. H., & Couvreur, P. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.09.005 · Cited by 397
Burton, G., Traber, M., Acuff, R., Walters, D., Kayden, H., Hughes, L., & Ingold, K. (1998) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/67.4.669 · Cited by 382
Immune responses to influenza virus infection
Kreijtz, J. H. C. M., Fouchier, R. A. M., & Rimmelzwaan, G. F. (2011) · Virus Research · doi:10.1016/j.virusres.2011.09.022 · Cited by 336
Risk factors of influenza transmission in households
Viboud, C., Boëlle, P.-Y., Cauchemez, S., Lavenu, A., Valleron, A.-J., Flahault, A., & Carrat, F. (2004) · International Congress Series · doi:10.1016/j.ics.2004.01.013 · Cited by 305
Valenciano, M., Kissling, E., Cohen, J.-M., Oroszi, B., Barret, A.-S., Rizzo, C., Nunes, B., Pitigoi, D., Larrauri Cámara, A., Mosnier, A., et al. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1000388 · Cited by 303
MF59 Design and Evaluation of a Safe and Potent Adjuvant for Human Vaccines
Ott, G., Barchfeld, G. L., Chernoff, D., Radhakrishnan, R., van Hoogevest, P., & Van Nest, G. (1995) · Pharmaceutical Biotechnology · doi:10.1007/978-1-4615-1823-5_10 · Cited by 298
Stephenson, I., Bugarini, R., Nicholson, K. G., Podda, A., Wood, J. M., Zambon, M. C., & Katz, J. M. (2005) · The Journal of Infectious Diseases · doi:10.1086/428948 · Cited by 285
Induction of Immunity to Human Immunodeficiency Virus Type-1 by Vaccination
McElrath, M. J., & Haynes, B. F. (2010) · Immunity · doi:10.1016/j.immuni.2010.09.011 · Cited by 270
Khurana, S., Chearwae, W., Castellino, F., Manischewitz, J., King, L. R., Honorkiewicz, A., Rock, M. T., Edwards, K. M., Del Giudice, G., Rappuoli, R., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000624 · Cited by 268
Immunogenicity and protective efficacy of influenza vaccination
Hannoun, C., Megas, F., & Piercy, J. (2004) · Virus Research · doi:10.1016/j.virusres.2004.02.025 · Cited by 260
Edelman, R. (1980) · Clinical Infectious Diseases · doi:10.1093/clinids/2.3.370 · Cited by 245
Long‐Term Efficacy and Immune Responses following Immunization with the RTS,S Malaria Vaccine
Stoute, J. A., Kester, K. E., Krzych, U., Wellde, B. T., Hall, T., White, K., Glenn, G., Ockenhouse, C. F., Garcon, N., Schwenk, R., et al. (1998) · The Journal of Infectious Diseases · doi:10.1086/515657 · Cited by 236
Sun, P., Schwenk, R., White, K., Stoute, J. A., Cohen, J., Ballou, W. R., Voss, G., Kester, K. E., Heppner, D. G., & Krzych, U. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.12.6961 · Cited by 232
Schultze, V., D’Agosto, V., Wack, A., Novicki, D., Zorn, J., & Hennig, R. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.03.093 · Cited by 227
Post-H1N1 Narcolepsy-Cataplexy
Dauvilliers, Y., Montplaisir, J., Cochen, V., Desautels, A., Einen, M., Lin, L., Kawashima, M., Bayard, S., Monaca, C., Tiberge, M., et al. (2010) · Sleep · doi:10.1093/sleep/33.11.1428 · Cited by 199
Antibody induction by influenza vaccines in the elderly: a review of the literature
Beyer, W. E. P., Palache, A. M., Baljet, M., & Masurel, N. (1989) · Vaccine · doi:10.1016/0264-410x(89)90150-3 · Cited by 194
Age-associated changes in immune and inflammatory responses: impact of vitamin E intervention
Wu, D., & Meydani, S. N. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0108023 · Cited by 187
Pellegrini, M., Nicolay, U., Lindert, K., Groth, N., & Della Cioppa, G. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.08.101 · Cited by 183
Modulation of signal transduction by vitamin E
Zingg, J.-M. (2007) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2006.12.009 · Cited by 171
Roman, F., Vaman, T., Gerlach, B., Markendorf, A., Gillard, P., & Devaster, J.-M. (2010) · Vaccine · doi:10.1016/j.vaccine.2009.12.014 · Cited by 167
Human cholesterol metabolism and therapeutic molecules
Charlton‐Menys, V., & Durrington, P. N. (2008) · Experimental Physiology · doi:10.1113/expphysiol.2006.035147 · Cited by 164
Swain, S. L., Agrewala, J. N., Brown, D. M., Jelley‐Gibbs, D. M., Golech, S., Huston, G., Jones, S. C., Kamperschroer, C., Lee, W., McKinstry, K. K., et al. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00388.x · Cited by 163
Moris, P., van der Most, R., Leroux-Roels, I., Clement, F., Dramé, M., Hanon, E., Leroux-Roels, G. G., & Van Mechelen, M. (2011) · Journal of Clinical Immunology · doi:10.1007/s10875-010-9490-6 · Cited by 162
Waddington, C. S., Walker, W. T., Oeser, C., Reiner, A., John, T., Wilkins, S., Casey, M., Eccleston, P. E., Allen, R. J., Okike, I., et al. (2010) · BMJ · doi:10.1136/bmj.c2649 · Cited by 161
Li, Y., Svehla, K., Mathy, N. L., Voss, G., Mascola, J. R., & Wyatt, R. (2006) · Journal of Virology · doi:10.1128/jvi.80.3.1414-1426.2006 · Cited by 159
Baras, B., Stittelaar, K. J., Simon, J. H., Thoolen, R. J. M. M., Mossman, S. P., Pistoor, F. H. M., van Amerongen, G., Wettendorff, M. A., Hanon, E., & Osterhaus, A. D. M. E. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001401 · Cited by 156
Leroux‐Roels, I., Bernhard, R., Gerard, P. P., Dramé, M., Hanon, E., & Leroux-Roels, G. G. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001665 · Cited by 151
Measurement of squalene in human tissues and plasma: validation and application
Liu, G. C., AHRENS, E. H., Schreibman, P. H., & Crouse, J. R. (1976) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37014-0 · Cited by 146
Regulation of gene expression by α-tocopherol
Azzi, A., Gysin, R., Kempná, P., Munteanu, A., Villacorta, L., Visarius, T. M., & Zingg, J.-M. (2004) · Biological Chemistry · doi:10.1515/bc.2004.072 · Cited by 139
Squalene synthase: a critical enzyme in the cholesterol biosynthesis pathway
Do, R., Kiss, R., Gaudet, D., & Engert, J. C. (2008) · Clinical Genetics · doi:10.1111/j.1399-0004.2008.01099.x · Cited by 125
Vitamin E ingestion improves several immune functions in elderly men and women
De la Fuente, M., Hernanz, A., Guayerbas, N., Manuel Victor, V., & Arnalich, F. (2008) · Free Radical Research · doi:10.1080/10715760801898838 · Cited by 124
2009 Pandemic Influenza A (H1N1) Deaths among Children—United States, 2009–2010
Cox, C. M., Blanton, L., Dhara, R., Brammer, L., & Finelli, L. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq011 · Cited by 121
Hardelid, P., Fleming, D., McMenamin, J., Andrews, N. J., Robertson, C. S., Sebastianpillai, P., Ellis, J., Carman, W. F., Wreghitt, T. G., Watson, J. M., et al. (2011) · Eurosurveillance · doi:10.2807/ese.16.02.19763-en · Cited by 111
Skowronski, D. M., Janjua, N. Z., Serres, G. D., Hottes, T. S., Dickinson, J. A., Crowcroft, N. S., Kwindt, T. L., Tang, P., Charest, H., Fonseca, K., et al. (2011) · BMJ · doi:10.1136/bmj.c7297 · Cited by 111
Vaccine Adjuvants Alter TCR-Based Selection Thresholds
Malherbe, L. P., Mark, L., Fazilleau, N., McHeyzer‐Williams, L. J., & McHeyzer‐Williams, M. G. (2008) · Immunity · doi:10.1016/j.immuni.2008.03.014 · Cited by 106
Wichmann, O., Stöcker, P., Poggensee, G., Altmann, D., Walter, D., Hellenbrand, W., Krause, G., & Eckmanns, T. (2010) · Eurosurveillance · doi:10.2807/ese.15.18.19561-en · Cited by 102
Mozdzanowska, K., Maiese, K., & Gerhard, W. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.5.2635 · Cited by 96
Nicholson, K. G., Abrams, K. R., Batham, S., Clark, T. W., Höschler, K., Lim, W. S., Medina, M. J., Nguyen‐Van‐Tam, J. S., Read, R. C., Warren, F. C., et al. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70296-6 · Cited by 95
Immunogenicity and safety of AS03-adjuvanted 2009 influenza A H1N1 vaccine in children 6–35 months
Carmona, A., Omeñaca, F., Torres, J. C. T., Merino, J., Vaman, T., Dieussaert, I., Gillard, P. H., & Arístegui, J. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.06.065 · Cited by 93
Langley, J. M., Frenette, L., Ferguson, L., Riff, D. S., Sheldon, E. A., Risi, G., Johnson, C., Li, P., Kenney, R. T., Innis, B. L., et al. (2010) · The Journal of Infectious Diseases · doi:10.1086/652701 · Cited by 93
Rümke, H. C., Bayas, J. M., de Juanes, J. R., Caso, C., Richardus, J. H., Campins, M., Rombo, L., Duval, X., Романенко, В. В., Schwarz, T. F., et al. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.02.068 · Cited by 92
Chu, D. W., Hwang, S., Lim, F. S., Oh, H. M. L., D, P. T. M., Yang, P., Bock, H. L., Dramé, M., Gillard, P. H., Hutagalung, Y., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.07.102 · Cited by 90
Puig‐Barberà, J., Arnedo-Pena, A., Pardo-Serrano, F., Tirado-Balaguer, M. D., Pérez-Vilar, S., Silvestre-Silvestre, E., Calvo-Mas, C., Safont-Adsuara, L., & Ruiz‐García, M. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.09.042 · Cited by 90
AS03A‐Adjuvanted Influenza A (H1N1) 2009 Vaccine for Adults up to 85 Years of Age
Roman, F. P., Vaman, T., Kafeja, F., Hanon, E., & Damme, P. V. (2010) · Clinical Infectious Diseases · doi:10.1086/655830 · Cited by 84
Economic Appraisal of Ontario's Universal Influenza Immunization Program: A Cost-Utility Analysis
Sander, B., Kwong, J. C., Bauch, C. T., Maetzel, A., McGeer, A., Raboud, J., & Krahn, M. D. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000256 · Cited by 83
Langley, J. M., Risi, G., Caldwell, M., Gilderman, L. I., Berwald, B., Fogarty, C. M., Poling, T. L., Riff, D. S., Baron, M., Frenette, L., et al. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir172 · Cited by 81
Self-citationCorrelates of protection: Novel generations of influenza vaccines
Rimmelzwaan, G. F., & McElhaney, J. E. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.07.043 · Cited by 79
Díez‐Domingo, J., Garcés‐Sánchez, M., Baldó, J.-M., Planelles, M. V., Ubeda, I., Jubert, A., Marés, J., Moris, P., Garcı́a-Corbeira, P., Dramé, M., et al. (2010) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181daf921 · Cited by 76
Andrews, N. J., Waight, P., Yung, C.-F., & Miller, E. (2010) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiq014 · Cited by 70
Madhun, A. S., Akselsen, P. E., Sjursen, H., Pedersen, G. K., Svindland, S. C., Nøstbakken, J. K., Nilsen, M. V., Mohn, K. G.-I., Jul‐Larsen, Å., Smith, I., et al. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.10.038 · Cited by 62
Roman, F. P., Clément, F., Dewé, W., Walravens, K., Maes, C., Willekens, J., Boever, F. D., Hanon, E., & Leroux-Roels, G. G. (2011) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00480-10 · Cited by 52
In vivo studies of sterol and squalene secretion by human skin
Nikkari, T., Schreibman, P. H., & AHRENS, E. H. (1974) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)36757-2 · Cited by 52
Örtqvist, Å., Berggren, I., Insulander, M., Jong, B. D., & Svenungsson, B. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir182 · Cited by 49
Protection of rams against epididymitis by a -vitamin E adjuvant vaccine
Afzal, M., Tengerdy, R. P., Ellis, R. P., Kimberling, C. V., & Morris, C. J. (1984) · Veterinary Immunology and Immunopathology · doi:10.1016/0165-2427(84)90087-4 · Cited by 45
Huijskens, E. G. W., Rossen, J. W. A., Mulder, P. G. H., van Beek, R., van Vugt, H., Verbakel, J., Rimmelzwaan, G. F., Koopmans, M., & Peeters, M. F. (2011) · Clinical and Vaccine Immunology · doi:10.1128/cvi.05046-11 · Cited by 45
Vitamin E in Viral Inactivated Vaccines
Franchini, A., BERTUZZI, S., Tosarelli, C., & Manfreda, G. (1995) · Poultry Science · doi:10.3382/ps.0740666 · Cited by 43
Monovalent inactivated split-virion AS03-adjuvanted pandemic influenza A (H1N1) vaccine
Walker, W. T., & Faust, S. N. (2010) · Expert Review of Vaccines · doi:10.1586/erv.10.141 · Cited by 38
Immunogenicity and safety of AS03-adjuvanted H1N1 pandemic vaccines in children and adolescents
García-Sicilia, J., Gillard, P. H., Carmona, A., Tejedor, J. C., Arı́stegui, J., Merino, J., Behre, U., Caplanusi, A., Vaman, T., & Dieussaert, I. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.04.011 · Cited by 34
Fragapane, E., Gasparini, R., Schioppa, F. S., et al. (2010) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00461-09 · Cited by 34
(2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00449.x · Cited by 31
Pelat, C., Falchi, A., Carrat, F., Mosnier, A., Bonmarin, I., Turbelin, C., Vaux, S., van der Werf, S., Cohen, J. M., Lina, B., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019621 · Cited by 26
Ho, J., Moir, S. L., Wang, W., Posada, J. G., Gu, W., Rehman, M. T., Dewar, R. J., Kovacs, C., Sneller, M. C., Chun, T., et al. (2010) · AIDS · doi:10.1097/qad.0b013e328342328b · Cited by 25
Ferrets and the Challenges of H5N1 Vaccine Formulation
Hampson, A. W. (2006) · The Journal of Infectious Diseases · doi:10.1086/505229 · Cited by 24
Baras, B., Stittelaar, K. J., Kuiken, T., Jacob, V., Bernhard, R., Giannini, S. L., de Waal, L., van Amerongen, G., Simon, J. H., Osterhaus, A. D. M. E., et al. (2011) · Vaccine · doi:10.1016/j.vaccine.2010.12.128 · Cited by 18
Cited by
Emerging concepts in the science of vaccine adjuvants
Pulendran, B., S. Arunachalam, P., & O’Hagan, D. T. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00163-y · Cited by 1,385
SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates
Kyriakidis, N. C., López-Cortés, A., González, E. V., Grimaldos, A. B., & Prado, E. O. (2021) · npj Vaccines · doi:10.1038/s41541-021-00292-w · Cited by 698
Correlates of adjuvanticity: A review on adjuvants in licensed vaccines
Del Giudice, G., Rappuoli, R., & Didierlaurent, A. M. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2018.05.001 · Cited by 610
Self-citationThe how’s and what’s of vaccine reactogenicity
Hervé, C., Laupèze, B., Del Giudice, G., Didierlaurent, A. M., & Tavares Da Silva, F. (2019) · npj Vaccines · doi:10.1038/s41541-019-0132-6 · Cited by 513
Self-citationVaccine adjuvants: Understanding the structure and mechanism of adjuvanticity
Shi, S., Zhu, H., Xia, X., Liang, Z., Ma, X., & Sun, B. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.04.055 · Cited by 423
Metadata
- Authors
- Garçon, N., Vaughn, D. W., & Didierlaurent, A. M.
- Venue
- Expert Review of Vaccines
- Publisher
- Informa UK Limited
- Published
- 2012-01
- Volume
- 11
- Issue
- 3
- Pages
- 349-366
- ISSN
- 1476-0584 (ISSN-L)
- 1744-8395
- OpenAlex
- W2103783169
- Cited by
- 347
- References
- 80
- FWCI
- 12.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.